A thoughtful look at investing opportunities and risks beyond the market headlines, plus personal finance and retirement tips, from Morningstar.
Total Ideas
11
With Returns
9
Equal-Weighted Return
+10.90%

""Walgreens is a business that has faced a lot of pressures and challenges for a number of years. A lot of us are customers of Walgreens. We know that retail is a really competitive cutthroat business... Its yield rose. And it ended up having to cut its dividend. And earlier this year, it was taken out by private equity.""
The discussion on Walgreens points to the unsustainable nature of its dividend payout, evidenced by an excessively high payout ratio and market pressures from intense competition and private equity involvement. This insight cautions income-focused investors regarding the potential risks in relying solely on high-yield dividend stocks.

""Dow Chemical, really well-known business at times considered a blue chip stock. Our stock analysts noted that in 2024, the company's dividend payments exceeded its free cash flows. So at one point, the yield surpassed 10%. But earlier this year, when the tariff announcements came out, tariffs stand to hit the company pretty hard.""
This commentary highlights that Dow Chemical exhibited unsustainable dividend practices, with dividends exceeding its free cash flows and external tariff pressures compounding risks. The analysis serves as a warning for income investors to be cautious of high-yield stocks that might be dividend traps.

"if you're in a really long duration bond, let's say a fund like iShares TLT, which focuses on treasury bonds with 20-year maturities or more, that fund was down about 31%"
The commentary warns investors about the risks associated with long-duration bond funds like iShares TLT in volatile interest rate scenarios, as evidenced by a 31% drop. This serves as a caution against excessive exposure to such funds in portfolios, especially in uncertain rate environments.

"ServiceNow is right at that border between three stars and four stars, trading at about a 14% discount to fair value today. They are benefiting from incorporating AI to drive efficiencies and higher operating margins."
ServiceNow is identified as an undervalued stock trading at a 14% discount to fair value. While its rating fluctuates between three and four stars, its potential to enhance efficiency through AI provides investors a compelling long-term buying opportunity.

"For companies that can utilize AI, Salesforce is a four star rated stock trading at a 22% discount, with a wide economic moat based on switching costs and network effect."
Salesforce is highlighted as a strong buy for investors seeking companies that benefit from AI integration into core products. With a 22% discount to fair value, a four-star rating, and strong competitive moats, it represents an attractive long-term investment.

"For the hyperscalers, it's going to be Microsoft. I would have said Alphabet, but Alphabet just got a favorable ruling. Microsoft is still a four star rated stock and trades at a 16% discount."
Microsoft is recommended as a prime hyperscaler benefiting from AI demand. Trading at a 16% discount to fair value and rated four-star, it is seen as an attractive long-term buy compared to its peers.

"The last of the hardware providers is going to be ASML. They make the machinery used to make the AI GPUs. ASML trades at a 24% discount and is a four star rated stock."
ASML, a key supplier in the AI chip production process, is trading at a 24% discount to fair value and holds a four-star rating. The recommendation targets investors looking to benefit from continued technological development in semiconductor manufacturing.

"Marvell stock has had some volatility recently. Our equity analyst team thinks that you need to look through kind of the short term volatility. That also is a four star rated stock, trades at a 30% discount to fair value."
The analyst recommends buying Marvell, which, despite recent volatility, is a four-star rated stock trading at a 30% discount to fair value. This presents a compelling opportunity for investors looking for undervalued exposure in AI hardware.

"First going to be Taiwan Semiconductor. It's a four star rated stock, trades at a 25% discount to fair value. It is a company we rate with a wide economic moat."
The analyst highlights Taiwan Semiconductor as an undervalued stock trading at a 25% discount relative to its fair value. With a four-star rating and a wide economic moat, it is presented as a strong buy for long-term investors in the AI hardware space.

"Pfizer, even though it increased its U.S. revenue exposure, is still generating about 40% of its revenue outside of the United States and is trading at a sizeable discount of around 34% to its fair value estimate."
Pfizer is presented as undervalued with a 34% discount, despite having 40% international revenue. This may indicate a buying opportunity for investors comfortable with international revenue exposure within a largely U.S.-dominated portfolio.

"I point to Edison International, which is a California-based utility generating all of its revenue in the United States, and it is currently trading at about a 31% discount to its Morningstar fair value estimate."
Edison International is highlighted as undervalued with a 31% discount to its fair value. For investors seeking U.S.-centric dividend exposure, this analysis suggests a potential buying opportunity given its full domestic revenue mix and pricing discount.